Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (6): 906-910    DOI: 10.31083/j.ceog.2020.06.5530
Original Research Previous articles | Next articles
Rectal misoprostol after cesarean delivery: does it affect recovery of bowel functions? A prospective randomized trial
N.K. Aref 1, *()
1Associate professor of Obstetrics and Gynecology, Faculty of Medicine, Taif University, Kingdom of Saudi Arabia
Download:  PDF(569KB)  ( 96 ) Full text   ( 13 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Aim: To assess the efficacy of rectally administered misoprostol in the improvement of bowel function recovery after cesarean delivery (CD). Methods: This prospective randomized trial was conducted among 171 pregnant women subjected to term elective CD. Patients were divided equally into 3 groups by simple randomization. Participants in group A were given misoprostol 200 μg rectally; those in group B were given misoprostol 400 μg rectally just after CD but before leaving the operating theater, while the participants in group C did not receive any rectal drug. The study outcome measures were: duration before first bowel movement and start of the regular oral diet. Adverse effects, need for additional analgesics, and post-CD hospital stay period were also recorded. Results: The mean times to first audible intestinal sounds and to the first passage of flatus were significantly lower in group B (14.1 ± 1.4 h and 16.7 ± 2.3 h, respectively) when compared to both groups A and C [ 21.9 ± 5.3 h and 24.9 ± 5.7 h (A) vs. 23.6 ± 6.9 h and 27.1 ± 7.9 h (C)] (p = 0.001). It was found that notably, patients in group B resumed diet more quickly, with a mean period of 20.5 h, which was significantly faster than the remaining groups (29.8 h and 33.1 h in groups A and C, respectively Of great interest, patients in group B had a lower post-CD hospital stay (38.5 h vs. 59.2 h in group A and 64. 8 h in group C). Conclusion: For the recovery of bowel functions after CD, rectal administration of 400 μg misoprostol appears to be more effective than 200 μg of rectally administrated misoprostol or traditional feeding regimens.
Key words:  Misoprostol      Bowel motility      Cesarean section      Post-CS recovery     
Submitted:  07 March 2020      Accepted:  15 May 2020      Published:  15 December 2020     
*Corresponding Author(s):  dr_magdygyn@yahoo.com; nisreenaref @yahoo.com (NISREEN KHALED AREF)   

Cite this article: 

N.K. Aref. Rectal misoprostol after cesarean delivery: does it affect recovery of bowel functions? A prospective randomized trial. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 906-910.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.06.5530     OR     https://ceog.imrpress.com/EN/Y2020/V47/I6/906

[1] Athanasia Tsaroucha, Aliki Tympa Grigoriadou, Tania Moshovou, Kassiani Theodoraki, Aikaterini Melemeni. Efficacy of intrathecally administered fentanyl versus dexmedetomidine for cesarean section: a double blinded, randomized clinical trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1065-1070.
[2] Eser Ağar, Seda Şahin Aker. Effect of sexual dysfunction on women's preference for delivery methods: a social media-based survey[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1154-1161.
[3] Uros Visic, Tatjana Stopar Pintaric, Tit Albreht, Iva Blajic, Miha Lucovnik. Multimodal stepwise analgesia for reducing opioid consumption after cesarean delivery[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1162-1166.
[4] Lorenz Hinterleitner, Herbert Kiss, Johannes Ott. The impact of Cesarean section on female fertility: a narrative review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 781-786.
[5] Dragan Belci, Gian Carlo Di Renzo, Davor Zoričić, Andrea Tinelli, Antonio Malvasi, Michael Stark. Less is more—a minimal approach technique for Cesarean Section[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 478-482.
[6] Eser Ağar, Gökhan Karakoç. Comparison of electrocautery and scalpel for blood loss and postoperative pain in Pfannenstiel incisions in recurrent cesarean sections: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 534-539.
[7] Lejla Kamerić, Anis Cerovac, Mirzeta Rizvanović, Alen Kamerić, Mahira Jahić, Dubravko Habek. Frequency of cesarean section in pregnant women with risk factors for preeclampsia: prospective cohort study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 561-566.
[8] Batool Ali H. Alkhazal, Majed Abdullah Halawani, Ibtihal Omar Alsahabi, Hassan S.O. Abduljabbar. The preferred mode of delivery among primigravida Middle Eastern Women. A questionnaire based study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 567-571.
[9] Faris Mujezinović, Veronika Anzeljc, Monika Sobočan, Iztok Takač. Do women in Slovenia prefer vaginal birth after prior caesarean and what hinders its successful outcome? A single institution retrospective analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 607-614.
[10] Ryuichi Shimaoka, Tomomi Shiga, Ken-ichirou Morishige. Change in uterine artery blood flow with intrauterine balloon tamponade[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 307-311.
[11] Bara'a Samara, Anton R. Sabella. The knowledge and attitudes of Palestinian women towards different childbirth delivery options[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 138-143.
[12] Wassan Nori, Muna Abdulghani, Ali B Roomi, Wisam Akram. To operate or to wait? Doppler indices as predictors for medical termination for first trimester missed abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 168-174.
[13] Jing Wang, Min Zhou, Li Zhang, Long-Xin Zhang. Effective doses 50% and 95% of subarachnoid injection of sufentanil with ropivacaine in lumbar anesthesia for cesarean section in severe preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 105-109.
[14] J.R. Huang, X. Li, C. Fu, Y.H. Deng, T. Gao, H.W. Zhang. Is preprocessing helpful for suction and curettage in treating cesarean scar pregnancy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 900-905.
[15] H. Takahashi, Y. Baba, R. Usui, S. Nagayama, K. Horie, A. Ohkuchi, S. Matsubara. Proteinuria as a novel risk factor for allogeneic blood transfusion irrespective of single or twin pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 709-713.
No Suggested Reading articles found!